GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

Flexion Therapeutics FLXN · USD

Health Care · US listing · 🇺🇸 United States

Compare

24.07

+0.92%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2020

Revenue

$85.5m

FY2014FY2020

Net income

−$113.7m

FY2014FY2020

Free cash flow

−$80.6m

FY2014FY2020

Shareholders' equity

−$16.7m

FY2014FY2020

Income statement

Fiscal years

FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue$85.5m$73.0m$22.5m$360,000———
Research and development$54.3m$69.6m$53.1m$51.2m$41.3m$32.7m$17.9m
Operating income−$93.0m−$136.3m−$159.2m−$129.7m−$69.8m−$46.1m−$27.0m
Net income−$113.7m−$149.8m−$169.7m−$137.5m−$71.9m−$46.3m−$27.3m
Diluted earnings per share-2.53-3.93-4.49-4.16-2.84-2.15-1.97

Balance sheet

At each fiscal year end

FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Total assets$251.9m$217.6m$295.8m$441.3m$226.3m$127.1m$153.3m
Cash and short-term investments$175.3m$136.7m$258.8m$392.4m$205.6m$111.2m$151.6m
Total liabilities$268.6m$237.7m$185.7m$181.0m$39.2m$23.2m$8.4m
Debt$223.7m$193.6m$158.5m$160.0m$30.5m$15.0m$3.6m
Shareholders' equity−$16.7m−$20.1m$110.1m$260.3m$187.0m$104.0m$144.9m
Shares outstanding45m38m38m33m25m22m14m

Cash flow

Fiscal years

FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations−$70.6m−$148.8m−$160.4m−$107.8m−$62.5m−$39.0m−$23.1m
Capital spending−$10.1m−$3.9m−$850,000−$2.1m−$8.4m−$5.2m−$800,000
Free cash flow−$80.6m−$152.6m−$161.3m−$110.0m−$70.9m−$44.2m−$23.9m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue519.4%——
Operating income-10.5%15.1%—
Net income-6.1%19.7%—

Share price return

Finished calendar years

2025
Return4%

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 27 Feb 2026.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.